Skip to main content

Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment.

Publication ,  Journal Article
Cairns, A; Jones, VM; Cronin, K; Yocobozzi, M; Howard, C; Lesko, N; Chiba, A; Howard-McNatt, M
Published in: Am Surg
June 2022

INTRODUCTION: The COVID-19 pandemic has impacted many areas of health care and had a significant impact on care delivery, including breast cancer. METHODS: To better understand the changes to detection and treatment of breast cancer at our institution, we analyzed mammogram rates (screening and diagnostic) and breast cancer operations in 2019-2020. Mammography rates were calculated using county level census data for eligible women (Z-test). For breast cancer staging, a stage severity score was analyzed with a Mann-Whitney U-test (two-tail, P < .05) with proportions derived from WFBH operative volume quarterly reports. Results: Data revealed a relative decline from 2019 to 2020 in breast cancer screening. Screening mammograms decreased by 44% or 1558 fewer screening mammograms (Z = 4.75, P < .00001) and by 21% or 771 fewer for diagnostic mammograms (Z = 2.16, P = .03). With regards to breast cancer operations, we did not identify a statistically significant difference in number of new breast cancer operations at WFBH with 340 cases in 2020 as compared to 384 cases in 2019 (P = .9905). We compared a breast cancer severity score (weighted by stage at time of operation), which did not reveal statistically significant difference in clinical stage of breast cancer at time of operation (P = .71, U = 28). CONCLUSION: Mammography was impacted more than breast surgery cases by the COVID-19 pandemic. More data needs to be collected to evaluate future morbidity and mortality related to breast cancer operations and persistent disparities related to delay in breast cancer care due to COVID-19.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Surg

DOI

EISSN

1555-9823

Publication Date

June 2022

Volume

88

Issue

6

Start / End Page

1051 / 1053

Location

United States

Related Subject Headings

  • Surgery
  • Pandemics
  • Mass Screening
  • Mammography
  • Humans
  • Female
  • Early Detection of Cancer
  • COVID-19
  • Breast Neoplasms
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cairns, A., Jones, V. M., Cronin, K., Yocobozzi, M., Howard, C., Lesko, N., … Howard-McNatt, M. (2022). Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment. Am Surg, 88(6), 1051–1053. https://doi.org/10.1177/00031348221087920
Cairns, Ashley, V Morgan Jones, Kelly Cronin, Margaret Yocobozzi, Clifford Howard, Nadja Lesko, Akiko Chiba, and Marissa Howard-McNatt. “Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment.Am Surg 88, no. 6 (June 2022): 1051–53. https://doi.org/10.1177/00031348221087920.
Cairns A, Jones VM, Cronin K, Yocobozzi M, Howard C, Lesko N, et al. Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment. Am Surg. 2022 Jun;88(6):1051–3.
Cairns, Ashley, et al. “Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment.Am Surg, vol. 88, no. 6, June 2022, pp. 1051–53. Pubmed, doi:10.1177/00031348221087920.
Cairns A, Jones VM, Cronin K, Yocobozzi M, Howard C, Lesko N, Chiba A, Howard-McNatt M. Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment. Am Surg. 2022 Jun;88(6):1051–1053.

Published In

Am Surg

DOI

EISSN

1555-9823

Publication Date

June 2022

Volume

88

Issue

6

Start / End Page

1051 / 1053

Location

United States

Related Subject Headings

  • Surgery
  • Pandemics
  • Mass Screening
  • Mammography
  • Humans
  • Female
  • Early Detection of Cancer
  • COVID-19
  • Breast Neoplasms
  • 3202 Clinical sciences